Ionis Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2025
Total Assets: $3.52B
Liabilities Breakdown FY2025
Total Liabilities: $3.03B
Asset Breakdown
Total Assets: $3.52B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $372.3M | 10.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $10.0M | 0.3% |
| Property, Plant & Equipment | $123.0M | 3.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $3.02B | 85.7% |
Liabilities Breakdown
Total Liabilities: $3.03B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $28.1M | 0.9% |
| Long-Term Debt | $1.33B | 43.8% |
| Other Liabilities | $1.68B | 55.3% |